Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.84 CAD | -1.18% | +2.44% | +1.20% |
29/01 | Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023 | CI |
2023 | Cannara Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
Sales 2022 | 35.84M 26.2M 2.19B | Sales 2023 | 57.26M 41.86M 3.49B | Capitalization | 90.41M 66.09M 5.51B |
---|---|---|---|---|---|
Net income 2022 | 2M 1.46M 122M | Net income 2023 | 6M 4.39M 366M | EV / Sales 2022 | 4.32 x |
Net Debt 2022 | 36.28M 26.52M 2.21B | Net Debt 2023 | 41.51M 30.35M 2.53B | EV / Sales 2023 | 2.3 x |
P/E ratio 2022 |
135
x | P/E ratio 2023 |
12.9
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 50.58% |
1 day | -1.18% | ||
1 week | +2.44% | ||
Current month | -9.68% | ||
1 month | -7.69% | ||
3 months | -6.67% | ||
6 months | -13.40% | ||
Current year | +1.20% |
Managers | Title | Age | Since |
---|---|---|---|
Zohar Krivorot
CEO | Chief Executive Officer | 48 | 31/18/31 |
Nicholas Sosiak
DFI | Director of Finance/CFO | - | 01/19/01 |
Avi Krivorot
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacob M. Kay
BRD | Director/Board Member | 83 | 25/19/25 |
Donald Olds
BRD | Director/Board Member | 64 | 10/20/10 |
Zohar Krivorot
CEO | Chief Executive Officer | 48 | 31/18/31 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.84 | -1.18% | 3,620 |
25/24/25 | 0.85 | +1.19% | 1,040 |
24/24/24 | 0.84 | +1.20% | 35,246 |
23/24/23 | 0.83 | +2.47% | 5,060 |
22/24/22 | 0.81 | -1.22% | 29,847 |
Delayed Quote Toronto S.E., April 26, 2024 at 09:58 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+1.20% | 55.24M | |
+31.96% | 272M | |
+33.74% | 261M | |
+49.42% | 194M | |
+44.98% | 131M | |
-28.57% | 121M | |
+115.91% | 119M | |
0.00% | 86.82M | |
+150.00% | 75.33M | |
+14.38% | 52.63M |
- Stock Market
- Equities
- LOVE Stock